Question to the Department of Health and Social Care:

To ask His Majesty's Government what discussions they have had with NHS trusts and pharmaceutical companies about the use of genomic testing to support cancer pathways.

NHS England commissions the NHS Genomic Medicine Service (NHS GMS) to provide standardised, high quality, and equitable access to genomic medicine across the National Health Service in England. NHS England and the Association of the British Pharmaceutical Industry have established an NHS Genomic Pharmaceutical Industry Strategic Advisory Group, to provide a framework for engagement with industry partners to support the strategic aims of the NHS GMS and system partners. This is a forum to align on priorities and identify mechanisms to support agreed improvements across the end-to-end genomics pathway, including in cancer, that will enable timely patient access to treatments and opportunities to participate in clinical trials.